|
Applied Biosystems and GeneGo Collaborate to Advance Understanding of Tissue Gene Expression (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif. & St. Joseph, Mich.----Aug. 3, 2006--Applied Biosystems , an Applera Corporation business, and GeneGo, Inc., a leading provider of software and databases for systems biology, today announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways.
(Aug 3, 2006)
Cell Signaling Technology Demonstrates the Discovery Capabilities of its PhosphoScan(R) Proteomics Platform with (Business Wire via Yahoo! Finance)
DANVERS, Mass.----Aug. 3, 2006--Cell Signaling Technology, Inc. announced today the publication of discovery research based on its patent-pending PhosphoScan® proteomics technology, which identified a mutant JAK3 tyrosine kinase as a novel driver in acute myeloid leukemia .
(Aug 3, 2006)
Piribo: Cytogenetics – the Next Big Thing? (PR Web via Yahoo! News)
(PRWEB) August 3, 2006 -- Piribo, [www.piribo.
(Aug 3, 2006)
Nanogen and Fisher Scientific Expand Molecular Diagnostics R&D Collaboration Agreement (FinanzNachrichten)
SAN DIEGO and HAMPTON, N.H., Aug. 3 /PRNewswire-FirstCall/ -- Nanogen, ( Nachrichten ) Inc. , a developer of advanced diagnostic products, and Fisher Scientific International ( Nachrichten ) Inc. announced today that the companies have expanded their relationship to include a research and development collaboration in molecular diagnostics.
(Aug 3, 2006)
Med BioGene reports promising pre-clinical results of its Diagnostic Lymphoma DNA Bioarray; biomarkers effective in (CNW Group via Yahoo! Finance)
Med BioGene Inc. is pleased to announce the results of its pre-clinical studies involving its Diagnostic Lymphoma Bioarray. The studies of fifty RNA samples derived from human lymphoma tissues suggest that MBI's Diagnostic Lymphoma Bioarray successfully differentiated between genes in both the diseased and healthy control samples.
(Aug 3, 2006)
FierceMarkets Launches FierceBioResearcher (pzone via Yahoo!7 Finance)
WASHINGTON, Aug. 3, 2006 (PRIMEZONE) -- In an expansion of its commitment to serving the biotech industry, FierceMarkets (www.fiercemarkets.com) today launched a new informational resource called FierceBioResearcher (http://www.fiercebioresearcher.com). Published every Thursday, the weekly newsletter and complementary Web site provide a one-stop source of critical news and information for
(Aug 3, 2006)
Biomatters ships Geneious Pro 2.01 (MacNN)
Biomatters has introduced Geneious Pro 2.01, a software solution that incorporates collaboration, sequence alignment editing and ClustalW to make bioinformatics easier for all scientists. Geneious is a self-organizing, automatically-updating library ...
(Aug 3, 2006)
JS-Sorcerer(TM) Accelerates Research at University of Connecticut Health Center (Business Wire via Yahoo! Finance)
RENTON, Wash.----Aug. 3, 2006--DHI Technologies, Inc., today announced that JS-Sorcerer helped create a cross-browser JavaScript application for scientists at the UConn Proteomics and Biological Mass Spectrometry Lab.
(Aug 3, 2006)
Device could do "battle" with hospital infections (UB Reporter)
An innovative UB air-sterilization technology that the U.S.
(Aug 3, 2006)
Study focuses on brain receptor in cognitive disorders (UB Reporter)
Only one drug is approved to treat persons with mild to moderate Alzheimer's symptoms, despite the fact that the brain protein at the core of this disease, the NMDA receptor, is known to play a central role in several acute and chronic neurodegenerative conditions that impair learning and memory.
(Aug 3, 2006)
WSU nabs $500K grant for cell study (Dayton Business Journal)
Wright State University Boonshoft School of Medicine has received a $500,000 grant for science research.
(Aug 3, 2006)
Power3 Chairman/CEO Steven Rash to be Back on MN1.com Radio Monday to Discuss Early Detection Blood Tests for Breast (Business Wire via Yahoo! Finance)
HOUSTON----Aug. 3, 2006--Steven Rash, chairman and CEO of Power3 Medical Products, Inc. , will be back on Market News First radio on Monday morning, August 7, at 9:30 a.m. CDT to discuss his company's progress in blood-based early detection testing for breast cancer and neurodegenerative diseases.
(Aug 3, 2006)
Information Systems for Biotechnology (ISB) News Report August 2006 (SeedQuest)
Perennial ryegrass ( Lolium perenne L.) is the most important pasture grass for meat, dairy and wool production in New Zealand, covering more than seven million hectares (Siegal et al., 1985). It is an out-crossing, wind pollinated and highly self-incompatible species and, for these reasons, the pace of genetic improvement has been slow through conventional breeding methods.
(Aug 3, 2006)
The Center of Nutrigenomics of the TU Munich licences Genomatix' Microarray Analysis Pipeline (EurekAlert!)
Genomatix Software GmbH and the The Center of Nutrigenomics of the Technical University Munich signed a multi-year license agreement, giving the Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.
(Aug 3, 2006)
Report: New test for breast cancer (PhysOrg)
An international research group led by Professor Jasminka Godovac-Zimmermann, UCL Medicine, has developed an ultra-sensitive blood test for breast cancer that could help to detect cancer at a very early stage and improve screening for the disease in younger women, for whom mammography is less sensitive.
(Aug 3, 2006)
Strategic Diagnostics Reports Second Quarter 2006 Results (Business Wire via Yahoo! Finance)
NEWARK, Del.----Aug. 3, 2006--Strategic Diagnostics Inc. - a leading provider of biotechnology-based detection solutions for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today reported financial results for the second quarter ended June 30, 2006.
(Aug 3, 2006)
Stratagene Announces Second Quarter 2006 Earnings Release Date and Conference Call (Business Wire via Yahoo! Finance)
LA JOLLA, Calif.----Aug. 3, 2006--Stratagene Corporation , today announced that it will release second quarter financial results on Tuesday, August 8, 2006 after the market close. The Company will also host a conference call and webcast on Tuesday, August 8, 2006 at 1:30 p.m.
(Aug 3, 2006)
Invitrogen Announces Second Quarter 2006 Results (Business Wire via Yahoo! Finance)
CARLSBAD, Calif.----Aug. 3, 2006--Invitrogen Corporation today announced results for its second quarter ended June 30, 2006. Revenues for the second quarter were $314 million, an increase of 2% over the $306 million reported for the second quarter of 2005.
(Aug 3, 2006)
DNA to the defense (EurekAlert!)
CAMBRIDGE, U.K., Fri., Aug 4, 2006 -- A team of scientists headed by Dr. Sara Melville at the University of Cambridge has shown that the parasite known to cause African sleeping sickness has evolved an unusual chromosomal structure as a result of environmental adaptation.
(Aug 3, 2006)
Invitrogen profit rises, sales miss expectations (Market Watch)
SAN FRANCISCO (MarketWatch) -- Shares of Invitrogen Corp. slumped 11.5% in late trade Thursday after the company posted a higher second-quarter profit but revenue that missed Wall Street's expectations.
(Aug 3, 2006)
GeneLogic genomics unit slides (Gazette.Net)
GeneLogic Inc. continues to report trouble in its genomics division, once the Gaithersburg company’s driving force. Most recently, GeneLogic said Tuesday it is cutting 80 jobs in the division and related administrative staff, effective Oct. 5.
(Aug 4, 2006)
Researchers Identify Gene As Protector Of DNA, Enemy Of Tumors (Science Daily)
A single gene plays a pivotal role launching two DNA damage detection and repair pathways in the human genome, suggesting that it functions as a previously unidentified tumor suppressor gene, researchers at the University of Texas M. D. Anderson Cancer Center report in Cancer Cell.
(Aug 4, 2006)
UNC may decide in fall on cleaning changes (The Herald-Sun)
As they continue their review of a controversial proposal to change the way housekeepers clean at the university, UNC officials expect to decide this fall on whether to implement the changes.
(Aug 4, 2006)
Church Hopes to Make DNA Decoding Accessible (The Harvard Crimson)
George Church shows off the machines that analyze DNA sequences. He hopes to significantly reduce the cost of sequencing human DNA. George M. Church wasted no time in revolutionizing the study of genetics.
(Aug 4, 2006)
Medal of Honour for Dundee scientist (BioDundee)
Professor Angus Lamond of the College of Life Sciences at the University of Dundee has been awarded the prestigious Medal of Honour from the First Medical Faculty of the Charles University Prague, in recognition of his innovative use of proteomics in the study of cell biology.
(Aug 4, 2006)
Human Tissue Generation Research To Move Forward with $1.6 Million Gift (Newswise)
Imagine swallowing a pill that could help heal a spinal injury or restore degenerating eyesight. Imagine applying a "smart bandage" to regenerate an amputated finger or the tissue of an unsightly wound, rather than undergoing reconstructive surgery. Sounds like science fiction. But drugs like these could be closer to reality than you think, thanks to the research by scientists of the IU Center
(Aug 4, 2006)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug (Market Wire via Yahoo! Finance)
DNAPrint Genomics, Inc. today announced that KBI BioPharma, Inc., has completed and validated a second analytical method for PT-401, based on SDS-PAGE, a well established separation technique that will be used for in-process analysis, release and stability testing for its PT-401 anemia drug, which is being developed by its subsidiary, DNAPrint Pharmaceuticals, Inc.
(Aug 4, 2006)
Gene Logic Reports Second Quarter 2006 Financial Results (Business Wire via Yahoo! Finance)
GAITHERSBURG, Md.----Aug. 4, 2006--Gene Logic Inc. today reported financial results for the second quarter ended June 30, 2006. Revenue Three Months Ended Six Months Ended June 30, 2006 June 30, 2006 ---------------------- ---------------------- % % 2006 2005 Change 2006 2005 Change ------- ------- ------ ------- ------- ------ Genomics Division $ 4,683 $14,166 -67% $13,431 $27,405 -51%
(Aug 4, 2006)
Gene Logic's Q2 Revenue Falls 44 Percent on Weak Genomics Results (GenomeWeb News)
Welcome to the New Home of GenomeWeb! GenomeWeb Daily News subscribers who have not yet registered and logged in to the new website should do so now. Begin by entering your email address in the space below. Then click .
(Aug 4, 2006)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug (SYS-CON Media)
DNAPrint Genomics, Inc. (OTCBB: DNAG) todayannounced that KBI BioPharma, Inc., has completed and validated a secondanalytical method for PT-401, based on SDS-PAGE, a well establishedseparation technique that will be used for in-process analysis, release andstability testing for its PT-401 anemia drug, which is being developed byits subsidiary, DNAPrint Pharmaceuticals, Inc.
(Aug 4, 2006)
DNAPrint Pharmaceuticals Completes the Development of a Second Assay for Its Anemia Drug (RedNova)
DNAPrint Genomics, Inc. (OTCBB: DNAG) today an
(Aug 4, 2006)
Invitrogen slumps on revenue miss, lowered forecast (Market Watch)
SAN FRANCISCO (MarketWatch) -- Invitrogen Corp. shares fell to their lowest point in nearly two years Friday, retreating after the company posted second-quarter revenue that missed Wall Street's expectations and cut its full-year forecast.
(Aug 4, 2006)
Applied Biosystems And GeneGo Collaborate To Advance Understanding Of Tissue Gene Expression (BioresearchOnline)
Applied Biosystems, an Applera Corporation business, and GeneGo, Inc., a provider of software and databases for systems biology, announced a collaboration designed to enhance researchers' ability to study differential gene expression in biological pathways
(Aug 4, 2006)
Ciphergen Biosystems, Inc. Announces Issuance of 2nd Quarter 2006 Financial Results and Events (PR Newswire via Yahoo! Finance)
Ciphergen Biosystems, Inc. , will announce 2nd Quarter 2006 Financial Results and Events on Monday, August 14, 2006 after market close.
(Aug 4, 2006)
Researchers identify how molecules of microRNA are responsible for the growth of blood vessels in a model for human (News-Medical-Net)
The process, called angiogenesis, results in ability of ravenous cancer cells to recruit blood vessels and receive a steady supply of nutrients and oxygen.
(Aug 4, 2006)
Human embryonic stem cells display a unique pattern of chemical modification to DNA (EurekAlert!)
San Diego, Calif. -- Scientists from the Burnham Institute for Medical Research (BIMR) and Illumina Inc., in collaboration with stem cell researchers around the world, have found that the DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern.
(Aug 4, 2006)
With Indonesia's say so, WHO to share bird flu data with scientific community (CP via Yahoo! Canada News)
(CP) - The World Health Organization on Friday welcomed the announcement that the Indonesian government had agreed to share with the global scientific community the genetic blueprints of the H5N1 avian flu viruses retrieved from human cases in that country.
(Aug 4, 2006)
Sequencing The Genome Of A New Kind Of Methane Producer (Science Daily)
Max Planck researchers uncover the survival strategy of microorganisms responsible for the worldwide emission of methane from rice paddies.
(Aug 4, 2006)
Galapagos and AstraZeneca enter drug discovery collaboration (Pharmaceutical Business Review)
Genomics-based drug company Galapagos has entered into a new drug discovery collaboration with AstraZeneca focusing on respiratory and inflammatory drugs.
(Aug 5, 2006)
Quantum Information Research Could Transform The Power Of Computing (Science Daily)
Although presently a very young field, Quantum Information Science and Technology (QIST) could well have a vital role to play in future information and communication technologies. Quantum computing and communication techniques have the potential to transform the way we think about computing power.
(Aug 5, 2006)
The Center Of Nutrigenomics Of The TU Munich Licences Genomatix Microarray Analysis Pipeline (Medical News Today)
Genomatix Software GmbH and the The Center of Nutrigenomics of the Technical University Munich signed a multi-year license agreement, giving the Center for Nurtigenomics full access to the Genomatix Microarray Analysis Pipeline.The Center of Nutrigenomics of the Technical University Munich headed by Prof. Hannelore Daniel is a leading institution of nutrition research. [click link for full
(Aug 5, 2006)
Device Could Do 'Battle' With Hospital Infections (Science Daily)
An innovative University at Buffalo air sterilization technology that the U.S. Department of Defense is funding to protect troops on the battlefield soon may be protecting hospital patients from deadly infections, thanks to recent funding from the New York State Office of Science, Technology and Academic Research (NYSTAR).
(Aug 5, 2006)
DNA of human embryonic stem cells is chemically modified in a characteristic, predictable pattern (News-Medical-Net)
Embryonic stem cells are derived from embryos that are undergoing a period of intense cellular activity, including the chemical addition of methyl groups to specific DNA sequences in a process known as DNA methylation.
(Aug 6, 2006)
Genetic breakthroughs usher in personalized medicine (The Palm Beach Post)
Matthew Green shaves, does his own laundry and can cook. He wiped down tables at the Beverly Hills Cafe in his hometown of Pembroke Pines until recently.
(Aug 6, 2006)
PM to visit Helsinki for India-EU summit in Oct (Hindustan Times)
Prime Minister Manmohan Singh will meet his Finnish counterpart Matti Vanhanen in Helsinki for the seventh India-EU summit on October 13 during which the two sides are expected to discuss a range of issues including fight against terrorism and cooperation in scientific research and technology Finland holds the 25-nation European Union's rotating presidency until the end of this year.
(Aug 6, 2006)
A chip off the auld sod (The Herald-Tribune)
This is a story about finding lost loved ones.
(Aug 6, 2006)
Neural Stem Cells Derived From Human Embryonic Stem Cells Carry Abnormal Gene Expression (Science Daily)
Neural stem cells grown from one of the federally approved human embryonic stem cell lines proved to be inferior to neural stem cells derived from fetal tissue donated for research, a UCLA study has found.
(Aug 6, 2006)
Water cooler (EETimes)
What's the latest and greatest news heard around the water cooler?
(Aug 6, 2006)
Family carries out vision for property (The Arizona Republic)
The first segment of developer John F. Long's 1,000-acre Algodón Center is aimed at forming a medical hub along Loop 101, a transportation corridor fast emerging as the West Valley's sports, entertainment and job center.
(Aug 7, 2006)
Scientists discover milk's healing power (AAP via Yahoo!7 News)
Milk's ability to keep teeth white and bones strong is well known but its benefits could extend to treating gut inflammation and helping skin repair.
(Aug 7, 2006)
|
